chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/4/2008 Over last couple days has nodular density popping up in the lateral left thigh. Same are varicella vaccine on Dec 20. Seen by MD Instructed if gets worse can use over the counter Tylenol and Benadryl
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 27-FEB-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R019391 with expiration date 05-JUL-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
5-4-08- temp 104; rash. 5-5-08 temp rash admitted to hospital. 5/27/2008 MR received for DOS 5/5-7/2008 with D/C DX: Fever and Rash. Infant presented to ER with 4 day hx of fever up to 104'F and rash which began 5/4/08 which was spreading. Infant had some nausea and vomiting over past few days as well.  PE (+) for irritability, fine, macular, blanching rash over torso, extremities and face. Bilateral inguinal lymph nodes palpated. TMs erythematous.  Conjunctival injection noted as well as cough and runny nose.  Intially thought to be Kawasaki's, but r/o by cardiology and ID.  Most c/w wild type measles. Measles cx (-). Rash faded over time and pt d/c.
Patient reported left ear pain, swelling of lymph nodes anterior cervical area one week post second dose. Then developed painful rash on face- diagnosed with shingles of face and eyelid. Patient is being referred to ophthalmology for evaluation and treatment.
Diffuse petechiae around eyelids bilaterally and forehead within 15 minutes of vaccine administration.
I have a terrible sore throat, cough, and chills. This has been going on for about 5 days. They did prescribe penicillin because I have some white spots on the back of my throat. They did a COVID-19 test and it was negative. They are pretty sure it is a bacterial infection.
This spontaneous report as received from a licensed practical nurse (also reported as registered nurse), refers to a 32 year old patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. On 02-DEC-2013, the patient was vaccinated with MMR II (Lot number J008882; expiry date, dose and route not provided). No co-suspect or concomitant therapies were reported. It was reported that the MMR II administered to the patient was exposed to temperatures above 8 degrees C (between 8.09 and 22.73 degrees C) during 42.78 hours, from 05-OCT-2013 until 09-OCT-2013. No adverse effect had been reported. This is one of several reports from the same reporter. Additional information has been requested.
Ringing in left ear.  Ongoing and high pitched for 3-4 straight days
Face paralysis on the left side within 10 hours of the injection.  More severe each day.
mom states pt w/sl fever, 1 loose BM & vomiting x 24hrs; no visible irritation @ inj site & pt normally active; mom states pt seen @ clinic & was told to cont clear fluids only x 24 hrs; GR-MTR advised by clinic co cont clear fluids x 24;
Gout attack in left foot/ gout flare; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0175) via an unspecified route of administration in the left arm on 30Apr2021 at 09:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0185) via an unspecified route of administration in the left arm on 21May2021 at 10:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included gout. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and cherry extract (MANUFACTURER UNKNOWN) all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 the patient experienced gout attack in left foot. The first attack was 17 days after the 1st Pfizer shot and 2nd gout flare started on 21Jun2021, 31days after 2nd dose. On Doctor advice the patient postponed steroid treatment until 48hours after 2nd COVID shot was received. Therapeutic measures were as a result of the event and included treatment with colchicine (MANUFACTURER UNKNOWN) and prednisone (MANUFACTURER UNKNOWN). The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the event of gout attack was recovered on an unknown date in 2021.
Pain in left arm at site of injection immediately following shot. Lasted four days. Severe body pain particularly in both upper arms, middle of quads, toes and flanks on backside. This started the night of vaccination. Last four days. Fever and chills day two, three and four. Highest recorded was 100.7 degrees. Treatment for all events consisted of Acetaminophen 2,000 mg three different times during the long weekend.
Rash on upper body; This is a spontaneous report from a contactable healthcare professional (patient). A 27-year-old female patient received the first dose of BNT162B2, intramuscularly in right arm on 08Jan2021 15:30 at single dose for COVID-19 immunization. Medical history was none. Concomitant medications were unspecified. On 10Jan2021 15:00, patient experienced rash on upper body. Treatment was not received for this event. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Transverse mylitis; angio edema; ataxia; vertigo; stiffness; mild confusion; This is a spontaneous report received from contactable reporter(s) (nurse). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Oct2021 11:00 (Batch/Lot number: unknown) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sarcoidosis" (unspecified if ongoing); "fibromyalgia" (unspecified if ongoing); "sojgrans" (unspecified if ongoing); "RA" (unspecified if ongoing). Concomitant medication(s) included: NIFEDIPINE; BENADRYL; CROMOLYN [CROMOGLICIC ACID]; OXYCODONE; FAMOTIDINE; CELLCEPT [MYCOPHENOLATE MOFETIL].  The following information was reported: MYELITIS TRANSVERSE (medically significant) with onset 07Oct2021 00:30, outcome "recovered with sequelae", described as "Transverse mylitis"; ANGIOEDEMA (medically significant) with onset 07Oct2021 00:30, outcome "recovered with sequelae", described as "angio edema"; ATAXIA (non-serious) with onset 07Oct2021 00:30, outcome "recovered with sequelae", described as "ataxia"; VERTIGO (non-serious) with onset 07Oct2021 00:30, outcome "recovered with sequelae", described as "vertigo"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 07Oct2021 00:30, outcome "recovered with sequelae", described as "stiffness"; CONFUSIONAL STATE (non-serious) with onset 07Oct2021 00:30, outcome "recovered with sequelae", described as "mild confusion". The events "transverse mylitis", "angio edema", "ataxia", "vertigo", "stiffness" and "mild confusion" were evaluated at the physician office visit. Therapeutic measures were taken as a result of myelitis transverse, angioedema, ataxia, vertigo, musculoskeletal stiffness, confusional state: Steroids benadryl asprin. The patient did not have COVID prior vaccination, and was not covid tested post vaccination.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient complained of itchy and dry throat. Denies swelling, difficulty breathing, and itching. The doctor on site evaluated her. Vital signs stable. Felt better after drinking water. No problem swallowing. Symptoms resolved completely and she was discharged from the vaccine clinic.
Got shot at 1:05pm 10/04/14.  Flew that night was feeling body aches.  Evening of 10/05/14 her arm was turning red.  Pt said went to urgent care clinic, told her to go to hospital. Was in hospital several days. Put on antibiotics.
I passed out on 4/10/2021 at around 10:15 am at home when I was just walking without any warning signs of dizziness etc. I hit my head, started frothing from the mouth, my eyes rolled up and my whole body stiff. My husband tried to wake me. I opened my eyes after 10 mins and asked him what happened, which he explained after which I went and laid down. After laying down for about 15 mins I regained consciousness. I did not remember anything that happened the past 30 mins..I completely blanked out. We went to the ER where they did blood work, pregnancy test, EKG, CT scan of Head and put me on telemetry for about 8 hours which all came out Normal. They diagnosed me as having a Seizure. I got discharged from the hospital with referral to see Cardiologist and Neurologist to get MRI of head and EEG. I went to my appointments, got MRI of head, EEG, EKG, ECHO and Holter monitor tests done which all came out normal. Both the specialists said I do not need any medication or treatment. I talked to the Infectious Disease specialists in the hospital where I work and they said I should immediately report it to CDC and I should not take my Second dose of Covid vaccine until cleared by CDC. My 2nd shot was due today 4/23/2021.
Excessive joint pain; Overall weakness; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 01Apr2021 at 17:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any other medications in two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 11Mar2021 at 17:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced excessive joint pain and overall weakness. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excessive joint pain and overall weakness was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient came to pharmacy requesting High Dose flu shot. Prescription was entered into computer and checked by pharmacist, with no DUR alerts. Patient was then administered the flu shot. Upon loading the immunization record into database, we discovered he had previously received Fluzone High-Dose also on 09/20/2023. We called patient's primary care physician and patient. Patient has experienced no adverse effects to their knowledge, except stomach pain one week later and dry skin.
Kept pt in clinic room a few minutes, post vax, talking to him. Stated he was ok and left clinic room. In the lobby, he passed out and hit back of the head on the floor. He was observed in clinic room; BP was stable; complained of nausea and was taken to doctor and dx'd with a concussion.
Pt received HPV, MENACTRA and TDAP on 4/1/15. Immediately after last vaccine was administered she stated not feeling well. She was lightheaded and felt nauseated. She never lost consciousness-was able to talk throughout. She layed down, then drank some juice and was feeling better. Phone call to her 2-3 hrs later-she said she felt fine.
had COVID-19; had COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and in May2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "allergies" (unspecified if ongoing), notes: has allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "had COVID-19".  Clinical course: Patient was asking if it is okay to get the Bivalent vaccine since she has had a sinus headache for about 3 months now and did home test twice but tested negative. Patient and her husband both had COVID-19 at the end Jun2022. Patient had both the Pfizer-BioNTech COVID-19 Vaccine, (monovalent) vaccines, have had the primary series and the booster doses x2. The patient and her husband both received their last booster dose in May2022. Patient and her husband both got COVID in Jun2022. She mentioned she has allergies so the cough is most likely associated with that but she just wanted to confirm.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient received a Varivax in left Deltoid received a second vaccine on her right deltoid which were a Tdap. After 1 minute patient c/o dizziness, nausea and weakness. Was very anxious, vomited yellowished matter (approximately 20cc ) Remained alert and oriented. Administered Epinephrin 0.3mg IM via auto-injector. VS: Pulse: 52, Resp: 22, O2sat 99% BP 90/60. Paramedics called. Patient recovered quickly.
Information has been received from a health professional concerning a 51 year old female with drug allergies to penicillin, iodine and Acetaminophen who on 11-FEB-2008 was vaccinated subcutaneously into the right upper arm with 0.5 ml, a booster dose of MMR II (lot # 655380/1326F). Concomitant therapy included ZYRTEC. On 23-APR-2008 the patient developed severe, intermittent, widespread muscle spasms. The muscle spasms affected primarily the left shoulder, low back and both legs. On 01 MAY 2008 the patient began to have persistent hiccups and widespread joint pain, in addition to the muscle spasms. The patient was referred to a neurologist who ordered a complete blood count, comprehensive metabolic panel, lipase, antinuclear antibody and started the patient on therapy with baciofen. The antibody test was negative, but other test results were pending at the time of reporting. The nurse noted that on 12 MAY 2008 the patient contacted the office with complaints of muscle weakness. A neurologist was consulted who recommended increasing the dose of baclofen. An MRI of the brain and electromyogram were ordered, the results of which were pending at the time of reporting. At the time of reporting the patient had not yet recovered. There was no product quality complaint. Additional information has been requested.
Red, hot, swollen, hard, painful, 2.5 inch raised area at injection site of the PPSV 13 vaccine. Arm difficult/sore to move, Nausea and loss of appetite, Lethargy started morning after vaccine given (approx. 18 hours). Swelling/inflammation beginning to subside on 4th day post vaccine. Nausea, loss of appetite, limb pain persist 5th day post vaccine.  Patient denied warm compress to site in attempt to alleviate inflammation. Oral analgesics minimally effective in relief of pain.
Received Tdap & PNEUMOVAX on 2/6/13 RT arm flat rash appeared approximately 2/11/13 given BACTRIM and took x 4 days to resolve.
COVID-19 TEST POSITIVE AFTER VACCINATION; This spontaneous report received from a patient via a company representative concerned a 3 decade old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced covid-19 test positive after vaccination. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive after vaccination was not reported. This report was non-serious. This report was associated with a product quality complaint 90000189095.
Large, painful lump in left armpit after shot. It's not going down, just getting larger...pain radiating down my arm also.
After being monitored for about 14 minutes, patient had a syncopal episode while sitting in the chair. He rolled from his chair onto the floor. He woke up within 3-5 seconds. Patient denied having any issues once he became alert. Call to patient next day and patient denied any other incidence.
Patient received second dose of COVID vaccine on 2/10/21.  She was given Moderna at this visit accidentally.  Nurse discovered after administration that the pt had received Pfizer as first dose on 1/19/21 and therefore was indicated to receive a second dose of Pfizer but had received Moderna instead.   Per CDC, no negative outcome or effect on immunity though highly undesirable to mix doses of these two vaccines.
This spontaneous report was received from a consumer refers to herself as a 72 year old female patient. The patient was allergic to penicillin. On an unknown date in 2011, the patient was vaccinated with ZOSTAVAX (dose, route and frequency was not reported) to prevent shingles. Concomitant medication included unspecified high blood pressure medication. On 06-JAN-2014, the patient experienced fever blister on her lip, a rash on her upper right leg and groin area and burning sensation in her back and buttocks. It was never blossomed any further, but was improved since then though she still has the rash. The patient reported that it hurts when her clothes rub up against her skin in the affected areas. The patient sought medical attention and called the physician. On 14-JAN-2014, the physician diagnosed the patient with shingles. The patient was treated with Valacyclovir and LYSINE tablets. The outcome of the event shingles was reported as recovering. The reporter did not provided the causality between the event and the suspect drug. Additional information has been requested.
INJECTION SITE TURNED RED AND ABOUT THE SIZE OF A QUARTER ON THURSDAY 5/31.
pt recv vax & 8SEP97 pt exp chickenpox mostly in diaper area;the reporter stated that the rash was definitely chickenpox not diaper rash;
Patient is on blood thinner and had quite some bleeding after receiving the flu vaccine on 10/15/18 for more than 5 minutes and continues bleeding after she got home and saw some bleeding the next day on on 10/16/18.
Bitterness in mouth; Nerve pain down left fingers; Nerve pain down right fingers; Extremely thirsty; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Bitterness in mouth), THIRST (Extremely thirsty), NEURALGIA (Nerve pain down right fingers) and NEURALGIA (Nerve pain down left fingers) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 062B20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced THIRST (Extremely thirsty). On 19-Mar-2021, the patient experienced NEURALGIA (Nerve pain down right fingers). On 16-Apr-2021, the patient experienced NEURALGIA (Nerve pain down left fingers). On 26-Apr-2021, the patient experienced DYSGEUSIA (Bitterness in mouth). At the time of the report, DYSGEUSIA (Bitterness in mouth), THIRST (Extremely thirsty), NEURALGIA (Nerve pain down right fingers) and NEURALGIA (Nerve pain down left fingers) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported.   This case was linked to MOD-2021-100619 (Patient Link).
Saturday around midnight my daughter woke up vomiting and had a fever. Sunday morning from about 5am-830am she would not stop vomiting, everything that went in came right out and she had a high fever. I gave her gripe water and the vomiting stopped but the fever continues. Sunday night the fever was as high as 103. Throughout today (Monday) her fever has been up and down.